BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26522391)

  • 1. Pitfalls and Artifacts in the Use of PET/CT in Oncology Imaging.
    Corrigan AJ; Schleyer PJ; Cook GJ
    Semin Nucl Med; 2015 Nov; 45(6):481-99. PubMed ID: 26522391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET/CT artifacts.
    Blodgett TM; Mehta AS; Mehta AS; Laymon CM; Carney J; Townsend DW
    Clin Imaging; 2011; 35(1):49-63. PubMed ID: 21237418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic performance of PET/CT with tracers other than F-18-FDG in oncology: an evidence-based review.
    Treglia G; Sadeghi R; Del Sole A; Giovanella L
    Clin Transl Oncol; 2014 Sep; 16(9):770-5. PubMed ID: 24647843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging spectrum and pitfalls of ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with tuberculosis.
    Ito K; Morooka M; Minamimoto R; Miyata Y; Okasaki M; Kubota K
    Jpn J Radiol; 2013 Aug; 31(8):511-20. PubMed ID: 23719763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Head and neck: normal variations and benign findings in FDG positron emission tomography/computed tomography imaging.
    Højgaard L; Berthelsen AK; Loft A
    PET Clin; 2014 Apr; 9(2):141-5. PubMed ID: 25030278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abdomen: normal variations and benign conditions resulting in uptake on FDG-PET/CT.
    Zukotynski K; Kim CK
    PET Clin; 2014 Apr; 9(2):169-83. PubMed ID: 25030280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hot-clot artifacts in the lung parenchyma on F-18 fluorodeoxyglucose positron emission tomography/CT due to faulty injection techniques: two case reports.
    Ozdemir E; Poyraz NY; Keskin M; Kandemir Z; Turkolmez S
    Korean J Radiol; 2014; 15(4):530-3. PubMed ID: 25053914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pitfalls and artifacts in 18FDG PET and PET/CT oncologic imaging.
    Cook GJ; Wegner EA; Fogelman I
    Semin Nucl Med; 2004 Apr; 34(2):122-33. PubMed ID: 15031812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-FDG PET in oncology.
    Núñez Miller R; Pozo MA
    Clin Transl Oncol; 2011 Nov; 13(11):780-6. PubMed ID: 22082641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain: normal variations and benign findings in fluorodeoxyglucose-PET/computed tomography imaging.
    Berti V; Mosconi L; Pupi A
    PET Clin; 2014 Apr; 9(2):129-40. PubMed ID: 24772054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography (PET) attenuation correction artefacts in PET/CT and PET/MRI.
    Buchbender C; Hartung-Knemeyer V; Forsting M; Antoch G; Heusner TA
    Br J Radiol; 2013 May; 86(1025):20120570. PubMed ID: 23580397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pitfalls and Limitations of PET/CT in Brain Imaging.
    Salmon E; Bernard Ir C; Hustinx R
    Semin Nucl Med; 2015 Nov; 45(6):541-51. PubMed ID: 26522395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron Emission Tomography Computed Tomography: A Guide for the General Radiologist.
    Beadsmoore C; Newman D; MacIver D; Pawaroo D
    Can Assoc Radiol J; 2015 Nov; 66(4):332-47. PubMed ID: 26277234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Positron-emission tomography/computed tomography: artifacts and pitfalls in cancer patients].
    Gorospe Sarasúa L; Echeveste Aizpurúa J; Raman S
    Radiologia; 2006; 48(4):189-204. PubMed ID: 17058646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorodeoxyglucose-PET/Computed Tomography-Guided Biopsy.
    Cerci JJ; Tabacchi E; Bogoni M
    PET Clin; 2016 Jan; 11(1):57-64. PubMed ID: 26590444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respiratory motion reduction in PET/CT using abdominal compression for lung cancer patients.
    Huang TC; Wang YC; Chiou YR; Kao CH
    PLoS One; 2014; 9(5):e98033. PubMed ID: 24837352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET-CT fusion imaging in differentiating physiologic from pathologic FDG uptake.
    Kostakoglu L; Hardoff R; Mirtcheva R; Goldsmith SJ
    Radiographics; 2004; 24(5):1411-31. PubMed ID: 15371617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-tumour 18F-FDG uptake heterogeneity decreases the reliability on target volume definition with positron emission tomography/computed tomography imaging.
    Dong X; Wu P; Sun X; Li W; Wan H; Yu J; Xing L
    J Med Imaging Radiat Oncol; 2015 Jun; 59(3):338-45. PubMed ID: 25708154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artifacts and diagnostic pitfalls in positron emission tomography-magnetic resonance imaging.
    Martinez-Rios C; Muzic RF; DiFilippo FP; Hu L; Rubbert C; Herrmann KA
    Semin Roentgenol; 2014 Jul; 49(3):255-70. PubMed ID: 25497910
    [No Abstract]   [Full Text] [Related]  

  • 20. Present and future role of FDG-PET/CT imaging in the management of head and neck carcinoma.
    Kitajima K; Suenaga Y; Sugimura K
    Jpn J Radiol; 2015 Dec; 33(12):776-89. PubMed ID: 26507982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.